 Analysis prognostic factors men metastatic prostate cancer Uro-Oncology Group Northern Alberta influence extent disease bone scan serum testosterone patient age performance status method initial diagnosis Gleason grade clinical stage diagnosis serum acid phosphatase serum prostate specific antigen PSA primary hormonal treatment survival clinical hormonal data presence metastatic disease treatment men metastatic prostate cancer Mean followup months months total men metastatic disease evaluation period Log analysis testosterone extent disease bone scan over-all survival trend towards survival values PSA values acid phosphatase extent disease bone scan significant independent prognostic factor Patient age performance status clinical stage method initial diagnosis Gleason grade type hormonal treatment influence survival multivariate Cox analysis extent disease bone scan over-all survival PSA influential duration followup necessary extent disease bone scan important prognosticator analyzed factors testosterone value